Bluejay Diagnostics Accounts Payable

Bluejay Diagnostics (BJDX) currently reports a accounts payable of $670K as of June 2026. That compares with $110K in the prior-year period — up 519.5% year over year. Use the charts on this page to explore Bluejay Diagnostics's accounts payable history and peer comparisons.

Bluejay Diagnostics's accounts payable increased from $110K to $670K — a 519.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bluejay Diagnostics reported $670K in accounts payable as of June 2026. That compares with $110K in the prior-year period — up 519.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $670K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bluejay Diagnostics, and consider following BJDX for alerts when major investors trade the stock.